Citations

Mayo Clinic

Clear

720 citation(s) found for "Núñez, Gabriel".

The USPSTF Recommendation Statement on Coronary Heart Disease Risk Assessment
Matteson, Eric L. , Crowson, Cynthia S., Gabriel, Sherine E., Crowson, Cynthia S., Gabriel, Sherine E.

Annals of Internal Medicine | April 12, 2013 | Volume: 152 | Issue: 6 | Pages: 405

10.7326/0003-4819-152-6-201003160-00018 | PMID 20231580 Get It

Effect of Previous Corticosteroid Treatment on Temporal Artery Biopsy Results
Achkar, Antonio A., Hunder, Gene G., Gabriel, Sherine E., Hunder, Gene G., Gabriel, Sherine E.

Annals of Internal Medicine | April 12, 2013 | Volume: 128 | Issue: 5 | Pages: 410

10.7326/0003-4819-128-5-199803010-00016 | PMID 9490606 Get It

Giant Cell Arteritis
Gabriel, Sherine E., Hunder, Gene G., Hunder, Gene G.

Annals of Internal Medicine | April 12, 2013 | Volume: 124 | Issue: 10 | Pages: 928

10.7326/0003-4819-124-10-199605150-00020 Get It

The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern
Gabriel, S. E., O’Fallon, W. Michael, Hunder, Gene G. , Salvarani, Carlo

Annals of Internal Medicine | April 12, 2013 | Volume: 123 | Issue: 3 | Pages: 192-194

10.7326/0003-4819-123-3-199508010-00006 | PMID 7598301 Get It

How Does Previous Corticosteroid Treatment Affect the Biopsy Findings in Giant Cell (Temporal) Arteritis?
Achkar, Antonio A., Lie, J. T., Hunder, Gene G., O'Fallon, W. Michael, Gabriel, Sherine E., Lie, J. T., Hunder, Gene G., O'Fallon, W. Michael, Gabriel, Sherine E.

Annals of Internal Medicine | April 12, 2013 | Volume: 120 | Issue: 12 | Pages: 987-992

10.7326/0003-4819-120-12-199406150-00003 | PMID 8185147 Get It

Brief Report: Rheumatoid Arthritis Is Associated With Left Ventricular Concentric Remodeling: Results of a Population‐Based Cross‐Sectional Study
Davis, John M. , Crowson, Cynthia S. , Roger, Véronique L. , Karon, Barry L., Borgeson, Daniel D., Therneau, Terry M. , Matteson, Eric L. , Rodeheffer, Richard J. , Gabriel, Sherine E., Myasoedova, Elena , Davis, John M

Arthritis & Rheumatism | April 1, 2013 | Volume: 65 | Issue: 7 | Pages: 1713-1718

10.1002/art.37949 | PMID 23553738 Get It

ObjectiveTo study left ventricular (LV) geometry in patients with rheumatoid arthritis (RA) and no history of heart failure compared with that in subjects with neither RA nor a history of heart failure, and to determine the impact of RA on LV remodeling.MethodsA cross‐sectional, community‐based study was conducted among adult (age ≥50 years) patients with RA and age‐ and sex‐matched subjects with neither RA nor a history of heart failure. All participants underwent standard 2‐dimensional Doppler echocardiography. LV geometry was classified into the following 4 categories based on relative wall thickness and sex‐specific cutoffs for the LV mass index: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, or normal geometry.ResultsAmong 200 patients with RA and 600 age‐ and sex‐matched subjects without RA, the mean age was 65 years, and 74% of the individuals in both cohorts were female. Compared with subjects without RA, patients with RA were significantly more likely to have abnormal LV geometry (odds ratio [OR] 1.44, 95% confidence interval [95% CI] 1.03–2.00), even after adjusting for cardiovascular risk factors and comorbidities. Among subjects with abnormal LV geometry, the odds of concentric LV remodeling were significantly increased in patients with RA (OR 4.73, 95% CI 2.85–7.83). In linear regression analyses, the LV mass index appeared to be lower in patients with RA who were currently receiving corticosteroids (β ± SE −0.082 ± 0.027, P = 0.002), even after adjusting for cardiovascular risk factors and comorbidities.ConclusionRA was strongly associated with abnormal LV remodeling (particularly concentric LV remodeling) among RA patients without heart failure. This association remained significant after adjustment for cardiovascular risk factors and comorbidities. RA disease–related factors may promote changes in LV geometry. The biologic mechanisms underlying LV remodeling warrant further investigation.
Incidence and Mortality of Obstructive Lung Disease in Rheumatoid Arthritis: A Population‐Based Study
Nannini, Carlotta, Medina, Yimy F. , Achenbach, Sara J., Crowson, Cynthia S. , Ryu, Jay H. , Vassallo, Robert , Gabriel, Sherine E., Matteson, Eric L. , Bongartz, Tim, Vassallo, Robert , Ryu, Jay H

Arthritis Care & Research | February 22, 2013 | Volume: 65 | Issue: 8 | Pages: 1243-1250

10.1002/acr.21986 | PMID 23436637 Get It

ObjectivePulmonary disease represents an important extraarticular manifestation of rheumatoid arthritis (RA). While the association of RA and interstitial lung disease is widely acknowledged, obstructive lung disease (OLD) in RA is less well understood. We therefore aimed to assess the incidence, risk factors, and mortality of OLD in patients with RA.MethodsWe examined a population‐based incident cohort of patients with RA and a comparison cohort of individuals without RA. OLD was defined using a strict composite criterion. Cox proportional hazards models were used to compare OLD incidence between the RA and comparator cohorts to investigate risk factors and to explore the impact of OLD on patient survival.ResultsA total of 594 patients with RA and 596 subjects without RA were followed for a mean of 16.3 and 19.4 years, respectively. The lifetime risk of developing OLD was 9.6% for RA patients and 6.2% for subjects without RA (hazard ratio [HR] 1.54, 95% confidence interval [95% CI] 1.01–2.34). The risk of developing OLD was higher among male patients, among current or former smokers, and for individuals with more severe RA. Survival of RA patients diagnosed with OLD was worse compared to those without OLD (HR 2.09, 95% CI 1.47–2.97).ConclusionPatients with RA are at higher risk of developing OLD, which is significantly associated with premature mortality. Effective diagnostic and therapeutic strategies to detect and manage OLD in patients with RA may help to improve survival in these patients.
Variability of Computational Fluid Dynamics Solutions for Pressure and Flow in a Giant Aneurysm: The ASME 2012 Summer Bioengineering Conference CFD Challenge
Steinman, David A. , Hoi, Yiemeng , Fahy, Paul, Morris, Liam , Walsh, Michael T. , Aristokleous, Nicolas , Αnayiotos, Αndreas , Papaharilaou, Yannis , Arzani, Amirhossein , Berg, Philipp , Janiga, Gábor , Bols, Joris, Bressloff, Neil W. , Cibiş, Merih , Gijsen, Frank H., Cito, Salvatore , Pallarès, Jordi , Browne, Leonard , Costelloe, J. A., Lynch, Adrian Gerard, Degroote, Joris , Vierendeels, Jan , Fu, Wenyu , Hodis, Simona , Kallmes, David F. , Kalsi, Hardeep S., Long, Quan , Kheyfets, Vitaly O. , Finol, Ender A. , Kono, Kenichi , Malek, Adel M. , Lauric, Alexandra, Menon, Prahlad G. , Pekkan, Kerem , Esmaily, Mahdi , Marsden, Alison L. , Oshima, M. , Katagiri, Kengo, Peiffer, Véronique, Mohamied, Yumnah, Sherwin, Spencer J. , Schaller, J. , Goubergrits, Leonid , Usera, Gabriel , Mendina, Mariana , Valen‐Sendstad, Kristian , Habets, Damiaan F., Xiang, Jianping , Yu, Yue , Karniadakis, George Em , Shaffer, Nicholas, Loth, Francis , Shadden, Shawn C. , Segers, Patrick , Gijsen, Frank , Qiao, Aike , Meng, Hui , Marsden, Alison

Journal of Biomechanical Engineering | January 18, 2013 | Volume: 135 | Issue: 2 | Pages: No page available

10.1115/1.4023382 | PMID 23445061 Get It

Stimulated by a recent controversy regarding pressure drops predicted in a giant aneurysm with a proximal stenosis, the present study sought to assess variability in the prediction of pressures and flow by a wide variety of research groups. In phase I, lumen geometry, flow rates, and fluid properties were specified, leaving each research group to choose their solver, discretization, and solution strategies. Variability was assessed by having each group interpolate their results onto a standardized mesh and centerline. For phase II, a physical model of the geometry was constructed, from which pressure and flow rates were measured. Groups repeated their simulations using a geometry reconstructed from a micro-computed tomography (CT) scan of the physical model with the measured flow rates and fluid properties. Phase I results from 25 groups demonstrated remarkable consistency in the pressure patterns, with the majority predicting peak systolic pressure drops within 8% of each other. Aneurysm sac flow patterns were more variable with only a few groups reporting peak systolic flow instabilities owing to their use of high temporal resolutions. Variability for phase II was comparable, and the median predicted pressure drops were within a few millimeters of mercury of the measured values but only after accounting for submillimeter errors in the reconstruction of the life-sized flow model from micro-CT. In summary, pressure can be predicted with consistency by CFD across a wide range of solvers and solution strategies, but this may not hold true for specific flow patterns or derived quantities. Future challenges are needed and should focus on hemodynamic quantities thought to be of clinical interest.
Incidence and Time Trends of Herpes Zoster in Rheumatoid Arthritis: A Population‐Based Cohort Study
Veetil, Bharath Manu Akkara, Myasoedova, Elena , Matteson, Eric L. , Gabriel, Sherine E., Green, Abigail B., Crowson, Cynthia S. , Myasoedova, Elena

Arthritis Care & Research | December 22, 2012 | Volume: 65 | Issue: 6 | Pages: 854-861

10.1002/acr.21928 | PMID 23281295 Get It

ObjectiveTo determine the incidence, time trends, risk factors, and severity of herpes zoster in a population‐based cohort of patients with newly diagnosed rheumatoid arthritis (RA) compared to a group of individuals without RA from the same population.MethodsAll residents of Olmsted County, Minnesota fulfilling for the first time the 1987 American College of Rheumatology criteria for RA between January 1, 1980 and December 31, 2007 and a cohort of similar residents without RA were assembled and followed by retrospective chart review until death, migration, or December 31, 2008.ResultsThere was no difference in the presence of herpes zoster prior to the RA incidence/index date between the cohorts (P = 0.85). During followup, 84 patients with RA (rate 12.1 cases per 1,000 person‐years) and 44 subjects without RA (rate 5.4 cases per 1,000 person‐years) developed herpes zoster. Patients with RA were more likely to develop herpes zoster than those without RA (hazard ratio [HR] 2.4 [95% confidence interval (95% CI) 1.7–3.5]). Herpes zoster occurred more frequently in patients diagnosed with RA more recently (HR 1.06 per year [95% CI 1.02–1.10]). Erosive disease, previous joint surgery, and use of hydroxychloroquine and corticosteroids were significantly associated with the development of herpes zoster in RA. There was no apparent association of herpes zoster with the use of methotrexate or biologic agents. Complications of herpes zoster occurred at a similar rate in both cohorts.ConclusionThe incidence of herpes zoster is increased in RA and has risen in recent years. There also has been an increasing incidence of herpes zoster in more recent years in the general population. RA disease severity is associated with the development of herpes zoster.
Neuromodulation: selected approaches and challenges
Silva, Gabriel A., Tass, Peter A. , Bennet, Kevin E. , Koehne, Jessica E. , Lee, Kendall H. , Andrews, Russell J. , Parpura, Vladimir , Meyyappan, Meyya

Journal of Neurochemistry | November 29, 2012 | Volume: 124 | Issue: 4 | Pages: 436-453

10.1111/jnc.12105 | PMID 23190025 Get It

AbstractThe brain operates through complex interactions in the flow of information and signal processing within neural networks. The ‘wiring’ of such networks, being neuronal or glial, can physically and/or functionally go rogue in various pathological states. Neuromodulation, as a multidisciplinary venture, attempts to correct such faulty nets. In this review, selected approaches and challenges in neuromodulation are discussed. The use of water‐dispersible carbon nanotubes has been proven effective in the modulation of neurite outgrowth in culture and in aiding regeneration after spinal cord injury in vivo. Studying neural circuits using computational biology and analytical engineering approaches brings to light geometrical mapping of dynamics within neural networks, much needed information for stimulation interventions in medical practice. Indeed, sophisticated desynchronization approaches used for brain stimulation have been successful in coaxing ‘misfiring’ neuronal circuits to resume productive firing patterns in various human disorders. Devices have been developed for the real‐time measurement of various neurotransmitters as well as electrical activity in the human brain during electrical deep brain stimulation. Such devices can establish the dynamics of electrochemical changes in the brain during stimulation. With increasing application of nanomaterials in devices for electrical and chemical recording and stimulating in the brain, the era of cellular, and even intracellular, precision neuromodulation will soon be upon us.